2026 Mitsui Chemicals Catalysis Science Awards
18.11.2025 03:00:00 CET | Business Wire | Press Release
Mitsui Chemicals, Inc. has announced that online applications for the 2026 Mitsui Chemicals Catalysis Science Award have been open since September 1, 2025. The application period will run from September 1 to December 25, 2025.
Aiming to contribute to the sustainable development of chemistry and the chemical industry, Mitsui Chemicals established the Mitsui Chemicals Catalysis Science Awards in 2004. The awards consist of the Catalysis Science Award and the Catalysis Science Award for Creative Work, which recognize outstanding achievements in the field of catalysis science. To date, the awards have been conferred on 33 researchers within Japan and overseas. Past recipients include individuals who have gone on to be highly acclaimed worldwide, receiving honors such as the Nobel Prize in Chemistry and other prestigious Japanese and international awards.
We welcome applications from a wide range of R&D fields, including solid catalysts, molecular catalysts and biocatalysts, as well as green processes and rare metal utilization via catalysis, along with materials science and development through novel catalysis.
2026 Mitsui Chemicals Catalysis Science Awards application site
https://jp.mitsuichemicals.com/en/techno/csa/index.htm
I. Outline of awards | ||
Mitsui Chemicals Catalysis
|
Mitsui Chemicals Catalysis Science
| |
Eligible
| Researchers affiliated to a university or public research institution, who have demonstrated extraordinary achievements in the field of catalysis science research (prize may be awarded to up to one winner) | Researchers affiliated to a university or public research institution, who have demonstrated creative achievements in the field of catalysis science research (prize may be awarded to up to two winners) |
Application
| Applicants must be 47 years old or younger as of April 1, 2025 | Applicants must be 37 years old or younger as of April 1, 2025 |
Prize | A plaque Monetary award: 5 million yen | A plaque Monetary award: 1 million yen |
II. Schedule and selection process | |
Application starts | September 1, 2025 |
Application closes | December 25, 2025 |
Announcement of
| In June 2026 or thereabouts (details will be published on the website and in professional journals, among other sources) |
The selection committee will comprise distinguished scholars in the field of catalysis science, along with a representative from Mitsui Chemicals.
For further details regarding the application process, required documents, and privacy policy, please refer to the website linked above.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251117870364/en/
Contacts
Mitsui Chemicals Catalysis Science Award Office
E-mail address for inquiries: mci-award@mitsuichemicals.com
Inquiry form -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fform.mitsuiche
micals.com%2Fcorporate%2Fcc_pr_csr_en%3Fparam%3D7%26_gl%3D1*y8w9q1*_gcl_au*NDUzN
zQzOTM3LjE3Mzk3NjA5MTE.%26_ifbs-cc_common_inquiry_en%3Ds1_Step1%26_ifbs-common_f
ooter%3Ds1_Step1%26_ifbs-common_header_en%3Ds1_Step1&esheet=54359060&newsitemid=
20251117870364&lan=en-US&anchor=Inquiry+form&index=2&md5=05eab3bffcda0f9c2a150c8
f3b7362b9
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VDYNE Receives FDA Approval to Initiate the TRIVITA 1 IDE Pivotal Trial of Transcatheter Tricuspid Valve Replacement System1.4.2026 15:30:00 CEST | Press Release
VDYNE, Inc. (“VDYNE” or “the Company”), a privately held medical device company developing next generation transcatheter valve replacement technologies, today announced that the U.S. Food & Drug Administration (FDA) has approved an investigational device exemption (IDE) for the company’s pivotal clinical trial evaluating its Transcatheter Tricuspid Valve Replacement (TTVR) system. The IDE approval enables initiation of a U.S. pivotal study at leading clinical centers to evaluate the safety and effectiveness of the VDYNE system in patients with severe tricuspid regurgitation (TR). “This is a defining milestone for VDYNE and an important step toward bringing a much-needed therapy to patients with severe tricuspid regurgitation,” said Mike Buck, Chief Executive Officer. “Our focus now is on disciplined clinical execution and partnering with leading investigators to generate high-quality data that advances the field and improves patient care.” Significant unmet clinical needs exist in the
NetJets Introduces State-of-the-Art, Exclusive-Use Terminal in Augusta, Georgia1.4.2026 15:05:00 CEST | Press Release
NetJets, the global leader in private aviation, is well underway on its development of a new exclusive-use terminal at Augusta Regional Airport (AGS). This state-of-the-art facility represents a significant investment in the region and reinforces NetJets’ commitment to delivering unparalleled experiences for its customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330125414/en/ NetJets to open a new, exclusive-use terminal at Augusta Regional Airport (AGS). Guests arriving this April for golf’s most iconic championship will witness the construction in progress, including the finished ramp and foundational walls of what will soon become a full-service terminal. The private ramp, offering 432,000 square feet of space for aircraft parking, will be completed in time for the 2026 golf tournament. “Augusta is a key destination for NetJets Owners,” said Patrick Gallagher, President, NetJets Aviation. “This new facility refl
Visa Unveils New Services to Modernize Dispute Resolution Process1.4.2026 15:00:00 CEST | Press Release
Visa (NYSE: V), a global leader in digital payments, today announced six new dispute resolution tools designed to reduce the billions of dollars lost annually to inefficient, outdated dispute processes. The expanded suite of dispute resolution services is being designed to help merchants and financial institutions cut administrative costs, reduce fraud-related losses and redirect those resources toward growth, innovation and customer experience. Disputes remain one of the most persistent friction points in commerce, driving rising costs for merchants and financial institutions while simultaneously leaving consumers frustrated and confused. In 2025, Visa processed 106 million disputes globally, a 35% increase since 20191. "Dispute management is moving from a back-office function to a strategic priority, driven by rising volumes, regulatory scrutiny, and growing pressure to protect customer experience," says Sam Abadir, Research Director, Risk, Compliance & Financial Crime, IDC Financial
Rimini Street Announces Debt Reduction and Amendment to its Credit Agreement1.4.2026 15:00:00 CEST | Press Release
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™, and the leading third-party support provider for Oracle, SAP and VMware software, today announced first quarter debt reduction activities and a recent amendment to its credit agreement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260401160360/en/ Rimini Street Announces Debt Reduction and Amendment to its Credit Agreement Debt reduction activities during the first quarter of 2026 totaled $10.9 million, reducing the Company’s outstanding term loan to $58.4 million as of March 31, 2026. The Company’s credit agreement was amended effective as of March 27, 2026 to increase to $20.0 million the value of Company common stock that could be repurchased per annum, beginning with the Company’s 2026 fiscal year and for each fiscal year thereafter, with a revised total of $50.0 million in permitted stock repurchases from the period beginning January
Neuphonic and Rapport Bring Real-Time Digital Humans to Everyday Hardware1.4.2026 15:00:00 CEST | Press Release
Neuphonic and Rapport (a division of Speech Graphics) today announced a partnership to deliver what they believe is among the first fully real-time, photorealistic digital human systems running entirely on standard CPU hardware. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260401782320/en/ Rapport and Neuphonic announce a partnership to deliver next-generation conversational AI experiences. The collaboration combines Neuphonic’s ultra-low latency text-to-speech technology with Rapport, an interactive AI avatar role play platform powered by production-proven real-time facial and full-body animation technology from Speech Graphics, used in video games such as Call of Duty, The Last of Us Part II and Hogwarts Legacy. Together, the system generates natural voice, perfectly synchronised lip movement and emotionally responsive facial performance in under 100 milliseconds — enabling digital characters that can speak, react and ex
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom